BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahamadi-Fesharaki R, Fateh A, Vaziri F, Solgi G, Siadat SD, Mahboudi F, Rahimi-Jamnani F. Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow. Mol Ther Oncolytics 2019;14:38-56. [PMID: 31011631 DOI: 10.1016/j.omto.2019.02.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Jeong J, Kim JS, Lee J, Seo YR, Yi EC, Kim KM. Neisseria gonorrhoeae Multivalent Maxibody with a Broad Spectrum of Strain Specificity and Sensitivity for Gonorrhea Diagnosis. Biomolecules 2021;11:484. [PMID: 33807121 DOI: 10.3390/biom11030484] [Reference Citation Analysis]
2 Ma J, Mo Y, Tang M, Shen J, Qi Y, Zhao W, Huang Y, Xu Y, Qian C. Bispecific Antibodies: From Research to Clinical Application. Front Immunol 2021;12:626616. [PMID: 34025638 DOI: 10.3389/fimmu.2021.626616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sokullu E, Gauthier MS, Coulombe B. Discovery of Antivirals Using Phage Display. Viruses 2021;13:1120. [PMID: 34200959 DOI: 10.3390/v13061120] [Reference Citation Analysis]
4 Donà MG, Di Bonito P, Chiantore MV, Amici C, Accardi L. Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies. Int J Mol Sci 2021;22:9143. [PMID: 34502053 DOI: 10.3390/ijms22179143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Suo F, Zhou X, Setroikromo R, Quax WJ. Receptor Specificity Engineering of TNF Superfamily Ligands. Pharmaceutics 2022;14:181. [PMID: 35057080 DOI: 10.3390/pharmaceutics14010181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Li H, Er Saw P, Song E. Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics. Cell Mol Immunol 2020;17:451-61. [PMID: 32313210 DOI: 10.1038/s41423-020-0417-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
7 Wu WH, Bai X, Shao Y, Yang C, Wei J, Wei W, Zhang WB. Higher Order Protein Catenation Leads to an Artificial Antibody with Enhanced Affinity and In Vivo Stability. J Am Chem Soc 2021;143:18029-40. [PMID: 34664942 DOI: 10.1021/jacs.1c06169] [Reference Citation Analysis]
8 Li S, Qiao Y, Jiang S, Wang B, Kong W, Shan Y. Broad and potent bispecific neutralizing antibody gene delivery using adeno-associated viral vectors for passive immunization against HIV-1. J Control Release 2021;338:633-43. [PMID: 34509584 DOI: 10.1016/j.jconrel.2021.09.006] [Reference Citation Analysis]
9 Liang GQ, Liu J, Zhou XX, Lin ZX, Chen T, Chen G, Wei H. Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity. Front Oncol 2020;10:571194. [PMID: 33392074 DOI: 10.3389/fonc.2020.571194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dkhar DS, Kumari R, Mahapatra S, Divya, Kumar R, Tripathi T, Chandra P. Antibody-receptor bioengineering and its implications in designing bioelectronic devices. Int J Biol Macromol 2022;218:225-42. [PMID: 35870626 DOI: 10.1016/j.ijbiomac.2022.07.109] [Reference Citation Analysis]
11 Liu L, Borlak J. Advances in Liver Cancer Stem Cell Isolation and their Characterization. Stem Cell Rev Rep. 2021;epub ahead of print. [PMID: 33432485 DOI: 10.1007/s12015-020-10114-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Pujol-Navarro N, Al Qaraghuli MM, Kubiak-Ossowska K, Alsaadi MM, Horne GA, Soutar RL, Paspali E, Ferro VA, Williams MT, Mulheran PA. Multiple myeloma: therapeutic delivery of antibodies and aptamers. Ther Deliv 2021;12:705-22. [PMID: 34569269 DOI: 10.4155/tde-2021-0041] [Reference Citation Analysis]
13 Soltanmohammadi B, Piri-Gavgani S, Basardeh E, Ghanei M, Azizi M, Khaksar Z, Sharifzadeh Z, Badmasti F, Soezi M, Fateh A, Azimi P, Siadat SD, Shooraj F, Bouzari S, Omrani MD, Rahimi-Jamnani F. Bactericidal fully human single-chain fragment variable antibodies protect mice against methicillin-resistant Staphylococcus aureus bacteraemia. Clin Transl Immunology 2021;10:e1302. [PMID: 34221401 DOI: 10.1002/cti2.1302] [Reference Citation Analysis]
14 Lejeune M, Köse MC, Duray E, Einsele H, Beguin Y, Caers J. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Front Immunol 2020;11:762. [PMID: 32457743 DOI: 10.3389/fimmu.2020.00762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
15 Diaz Arguello OA, Haisma HJ. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy. Cancers (Basel) 2021;13:1543. [PMID: 33801589 DOI: 10.3390/cancers13071543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lin Y, Chen Z, Hu C, Chen Z, Zhang L. Recent progress in antitumor functions of the intracellular antibodies. Drug Discovery Today 2020;25:1109-20. [DOI: 10.1016/j.drudis.2020.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Register AC, Tarighat SS, Lee HY. Bioassay Development for Bispecific Antibodies-Challenges and Opportunities. Int J Mol Sci 2021;22:5350. [PMID: 34069573 DOI: 10.3390/ijms22105350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ledsgaard L, Ljungars A, Rimbault C, Sørensen CV, Tulika T, Wade J, Wouters Y, McCafferty J, Laustsen AH. Advances in antibody phage display technology. Drug Discov Today 2022:S1359-6446(22)00173-8. [PMID: 35550436 DOI: 10.1016/j.drudis.2022.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Trier N, Hansen P, Houen G. Peptides, Antibodies, Peptide Antibodies and More. Int J Mol Sci 2019;20:E6289. [PMID: 31847088 DOI: 10.3390/ijms20246289] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
20 Abramson HN. B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma. Int J Mol Sci 2020;21:E5192. [PMID: 32707894 DOI: 10.3390/ijms21155192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]